Hepion Pharmaceuticals, Inc.
HEPA
$0.04
-$0.02-27.83%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 349.83% | 55.04% | 38.27% | -65.00% | -97.25% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.87% | -0.98% | -53.05% | -25.49% | -55.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 90.25% | 5.95% | -17.82% | -59.05% | -90.77% |
|
|
|||||
| Total Current Assets | 90.25% | 5.95% | -17.82% | -59.05% | -90.77% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 90.25% | 0.68% | -25.04% | -60.48% | -91.08% |
|
|
|||||
| Total Accounts Payable | -23.80% | -58.56% | -61.32% | -83.75% | -90.63% |
| Total Accrued Expenses | 227.00% | -81.73% | -87.07% | -79.02% | -98.64% |
| Short-term Debt | -98.13% | -89.82% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -90.48% | -87.21% | -39.23% | -63.64% | -40.57% |
|
|
|||||
| Total Current Liabilities | -90.48% | -87.21% | -39.23% | -63.64% | -40.57% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -98.13% | -89.82% | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -69.09% | -95.13% | -92.14% | -74.60% | -93.86% |
| Total Liabilities | -88.43% | -89.91% | -71.06% | -71.39% | -67.85% |
|
|
|||||
| Common Stock & APIC | 5.47% | 5.48% | 5.89% | 5.50% | 1.72% |
| Retained Earnings | -3.48% | -3.88% | -5.86% | -7.23% | -5.87% |
| Treasury Stock & Other | 0.00% | 115.43% | 115.43% | -9.78% | 110.53% |
| Total Common Equity | 127.33% | 177.52% | 12.59% | -62.22% | -163.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 127.33% | 177.52% | 12.59% | -62.22% | -163.71% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 243.16% | 917.41% | 6.60% | -48.20% | -125.59% |
|
|
|||||